NM_000219.6:c.374C>T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_000219.6(KCNE1):​c.374C>T​(p.Thr125Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T125R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00030 ( 1 hom., cov: 16)
Exomes 𝑓: 0.000094 ( 0 hom. )

Consequence

KCNE1
NM_000219.6 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8O:1

Conservation

PhyloP100: -2.70

Publications

10 publications found
Variant links:
Genes affected
KCNE1 (HGNC:6240): (potassium voltage-gated channel subfamily E regulatory subunit 1) The product of this gene belongs to the potassium channel KCNE family. Potassium ion channels are essential to many cellular functions and show a high degree of diversity, varying in their electrophysiologic and pharmacologic properties. This gene encodes a transmembrane protein known to associate with the product of the KVLQT1 gene to form the delayed rectifier potassium channel. Mutation in this gene are associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
KCNE1 Gene-Disease associations (from GenCC):
  • long QT syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Jervell and Lange-Nielsen syndrome 2
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016434193).
BP6
Variant 21-34449261-G-A is Benign according to our data. Variant chr21-34449261-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 132679.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNE1NM_000219.6 linkc.374C>T p.Thr125Met missense_variant Exon 4 of 4 ENST00000399286.3 NP_000210.2 P15382C7S316Q6FHJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNE1ENST00000399286.3 linkc.374C>T p.Thr125Met missense_variant Exon 4 of 4 1 NM_000219.6 ENSP00000382226.2 P15382

Frequencies

GnomAD3 genomes
AF:
0.000269
AC:
31
AN:
115348
Hom.:
1
Cov.:
16
show subpopulations
Gnomad AFR
AF:
0.000727
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000268
Gnomad ASJ
AF:
0.000383
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000628
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000193
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000144
AC:
36
AN:
250166
AF XY:
0.000118
show subpopulations
Gnomad AFR exome
AF:
0.000871
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000443
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000940
AC:
83
AN:
883038
Hom.:
0
Cov.:
12
AF XY:
0.0000924
AC XY:
42
AN XY:
454306
show subpopulations
African (AFR)
AF:
0.000755
AC:
17
AN:
22530
American (AMR)
AF:
0.000173
AC:
7
AN:
40512
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20188
East Asian (EAS)
AF:
0.0000828
AC:
3
AN:
36222
South Asian (SAS)
AF:
0.000198
AC:
14
AN:
70876
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51446
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4634
European-Non Finnish (NFE)
AF:
0.0000604
AC:
36
AN:
595876
Other (OTH)
AF:
0.000147
AC:
6
AN:
40754
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000303
AC:
35
AN:
115450
Hom.:
1
Cov.:
16
AF XY:
0.000306
AC XY:
17
AN XY:
55540
show subpopulations
African (AFR)
AF:
0.000846
AC:
28
AN:
33100
American (AMR)
AF:
0.000268
AC:
3
AN:
11206
Ashkenazi Jewish (ASJ)
AF:
0.000383
AC:
1
AN:
2610
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3286
South Asian (SAS)
AF:
0.000630
AC:
2
AN:
3174
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7792
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
212
European-Non Finnish (NFE)
AF:
0.0000193
AC:
1
AN:
51870
Other (OTH)
AF:
0.00
AC:
0
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000143
Hom.:
0
Bravo
AF:
0.000321
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000165
AC:
20
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 29, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24478792, 25637381, 24710009, 19716085, 26899768, 28988457, 29884292, 31941373) -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Long QT syndrome Uncertain:1Benign:1
Jun 01, 2014
CSER _CC_NCGL, University of Washington
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Low GERP score may suggest that this variant may belong in a lower pathogenicity class -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 15, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Thr125Met in exon 3 of KCNE1: This variant is not expected to have clinical sig nificance because the threonine (Thr) residue at position 125 is not conserved a cross species, with chimpanzee, gorilla, and four additional mammals having a me thionine (Met) at this position. -

Long QT syndrome 5 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jervell and Lange-Nielsen syndrome 2 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Cardiovascular phenotype Benign:1
Mar 28, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Congenital long QT syndrome Other:1
-
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
0.052
DANN
Benign
0.71
DEOGEN2
Uncertain
0.44
T;T;T;T;T;T;T;T
Eigen
Benign
-2.2
Eigen_PC
Benign
-2.3
FATHMM_MKL
Benign
0.0024
N
LIST_S2
Benign
0.33
.;.;T;.;.;.;.;.
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.016
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
0.26
N;N;N;N;N;N;N;N
PhyloP100
-2.7
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.73
N;.;.;N;N;N;N;N
REVEL
Uncertain
0.47
Sift
Benign
0.13
T;.;.;T;T;T;T;T
Sift4G
Benign
0.16
T;T;T;T;T;T;T;T
Polyphen
0.010
B;B;B;B;B;B;B;B
Vest4
0.32
MVP
0.43
MPC
0.079
ClinPred
0.0042
T
GERP RS
-9.9
Varity_R
0.013
gMVP
0.26
Mutation Taster
=1/99
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142511345; hg19: chr21-35821559; COSMIC: COSV61606624; API